Work

Corrigendum to “Miglitol-PMO nanoparticles, an alpha-glucosidase inhibitor, has prolonged action on blood glucose level in diabetic rats” [J. Drug Deliv. Sci. Technol. 72 (2022) 103388]

Year: 2022

Type: erratum

Source: Journal of Drug Delivery Science and Technology

DOI: 10.1016/j.jddst.2022.103647

Authors: Ahmed Salem, A.S. Montaser, Mona M. El-Naa, Gina S. El-Feky, Samah El-Ghlban, Abd El-Monem Abd El-Kader El-Torgoman, Mohamed F. Attia, Daniel C. Whitehead

Institutions: National Research Centre, Menoufia University, University of Sadat City, University of North Carolina at Chapel Hill, Clemson University

Language: English

Topic: Advanced Drug Delivery Systems

Subfield: Pharmaceutical Science

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4293769783

Cites:

Cited by:

Related to: 10